Search

Streptococcus gallolyticus sp. gallolyticus (SGG) is a gut pathobiont involved in the development of colorectal cancer (CRC). To decipher SGG contribution in tumor initiation and/or acceleration respectively, a global transcriptome was performed in human normal colonic cells (FHC) and in human tumoral colonic cells (HT29). To identify SGG-specific alterations, we chose the phylogenetically closest relative, Streptococcus gallolyticus subsp. macedonicus (SGM) as control bacterium. We show that SGM, a bacterium generally considered as safe, did not induce any transcriptional changes on the two human colonic cells. The transcriptional reprogramming induced by SGG in normal FHC and tumoral HT29 cells was significantly different, although most of the genes up- and down-regulated were associated with cancer disease. Top up-regulated genes related to cancer were: (i) IL-20, CLK1, SORBS2, ERG1, PIM1, SNORD3A for normal FHC cells and (ii) TSLP, BHLHA15, LAMP3, ZNF27B, KRT17, ATF3 for cancerous HT29 cells. The total number of altered genes were much higher in cancerous than in normal colonic cells (2,090 vs 128 genes being affected, respectively). Gene set enrichment analysis reveals that SGG-induced strong ER- (endoplasmic reticulum) stress and UPR- (unfolded protein response) activation in colonic epithelial cells. Our results suggest that SGG induces a pro-tumoral shift in human colonic cells particularly in transformed cells potentially accelerating tumor development in the colon. [ABSTRACT FROM AUTHOR]

Streptococcus gallolyticus (formerly known as Streptococcus bovis biotype I) is an increasing cause of endocarditis among streptococci and frequently associated with colon cancer. S. gallolyticus is part of the rumen flora but also a cause of disease in ruminants as well as in birds. Here we report the complete nucleotide sequence of strain UCN34, responsible for endocarditis in a patient also suffering from colon cancer. Analysis of the 2,239 proteins encoded by its 2,350-kb-long genome revealed unique features among streptococci, probably related to its adaptation to the rumen environment and its capacity to cause endocarditis. S. gallolyticus has the capacity to use a broad range of carbohydrates of plant origin, in particular to degrade polysaccharides derived from the plant cell wall. Its genome encodes a large repertoire of transporters and catalytic activities, like tannase, phenolic compounds decarboxylase, and bile salt hydrolase, that should contribute to the detoxification of the gut environment. Furthermore, S. gallolyticus synthesizes all 20 amino acids and more vitamins than any other sequenced Streptococcus species. Many of the genes encoding these specific functions were likely acquired by lateral gene transfer from other bacterial species present in the rumen. The surface properties of strain UCN34 may also contribute to its virulence. A polysaccharide capsule might be implicated in resistance to innate immunity defenses, and glucan mucopolysaccharides, three types of pili, and collagen binding proteins may play a role in adhesion to tissues in the course of endocarditis. doi: 10.1128/JB.01659-09

In streptococci, the secA2 locus includes genes encoding the following: (i) the accessory Sec components (SecA2, SecY2, and at least three accessory secretion proteins), (ii) two essential glycosyltranferases (GTs) (GtfA and GtfB), (iii) a variable number of dispensable additional GTs, and (iv) a secreted serine-rich LPXTG protein which is glycosylated in the cytoplasm and transported to the cell surface by this accessory Sec system. The secA2 locus of Streptococcus agalactiae strain NEM316 is structurally related to those found in other streptococci and encodes the serine-rich surface protein Srr1. We demonstrated that expression of Srr1 but not that of the SecA2 components and the associated GTs is regulated by the standalone transcriptional regulator Rga. Srr1 is synthesized as a glycosylated precursor, secreted by the SecA2 system, and anchored to the cell wall by the housekeeping sortase A. Srr1 was localized preferentially at the old poles. GtfA and/or GtfB, but not the six additional GTs, is essential for the production of Srr1. These GTs are involved in the attachment of GlcNac and sialic acid to Srr1. Full glycosylation of Srr1 is associated with the cell surface display of a protein that is more resistant to proteolytic attack. Srrl contributes to bacterial adherence to human epithelial cell lines and virulence in a neonatal rat model. The extent of Srr1 glycosylation by GtfC to -H modulates bacterial adherence and virulence.

Antimicrobial drugs targeting the reportedly essential type II fatty acid synthesis (FASII) pathway'-s have been recently acclaimed for their efficacy against infections caused by multiresistant Gram-positive bacteria (6-8). Our findings show that the strategy for antibiotic development based on FASII pathway targets is fundamentally flawed by the fact that exogenous fatty acids fully bypass inhibition of this pathway in both in vitro and in vivo conditions. We demonstrate that major Gram-positive pathogens--such as streptococci, pneumococci, enterococci and staphylococci--overcome drug-induced FASII pathway inhibition when supplied with exogenous fatty acids, and human serum proves to be a highly effective source of fatty acids. For opportunist pathogen Streptococcus agalactiae, growth in serum leads to an overall decrease of FASII gene expression. No antibiotic inhibitor could have a stronger effect than the inactivation of the target gene, so we challenged the role of FASII using deletion mutants. Our results unequivocally show that the FASII target enzymes are dispensable in vivo during S. agalactiae infection. The results of this study largely compromise the use of FASII-based antimicrobials for treating sepsis caused by Gram-positive pathogens., The bacterial FASII pathway is considered a promising target for the development of novel antimicrobial drugs (1-5). The recently described drugs platensimycin and platencin, which were shown to target key [...]

The authors review the presentations carried out by the researches at the Sixth International Conference on Streptococcal, Lactococcal and Enterococcal Genetics convened in 2002 in Asheville, N.C. The topics of interest include the role of streptococcal, lactococcal and enterococcal species in bacterial genetics development and the discovery and analysis of yet-to-be-cultured microbes and microbes colonizing oral cavity, respiratory tract and intestinal system.

Research has been conducted on the gram-positive bacteria dlt operon that comprises genes catalyzing the D-alanine residue incorporation into the lipoteichoic acids. The characterization of the dlt operon of Streptococcus agalactiae has been carried out and the results are reported.

Research was conducted to examine the distribution of IS1358 in Vibrio Cholerae strains from various serovars. Several copies of the IS in O22 and O155 strains, which contained O-antigen factors in common with strains from serovar O139, were characterized. A comparison of their nucleotide sequences with those of O1 and O139 showed that they were almost identical. Results reveal that IS1358 duplicates 10 bp at its insertion site.

Molecular characterization of IS1541 insertions in the genome of Yersinia pestis was conducted. It was found that no IS element was inserted into large open reading frames. However, IS elements were detected downstream in eight cases and only once upstream. Sequence analysis shows stem-loop structures similar to rho-independent transcription terminators in 8 of the 14 insertion sites.

An excision reporter plasmid pTCR9 was created to qualitatively and quantitatively characterize the intracellular mobility of the conjugative transposon Tn916 in various Gram-positive bacteria including isogenic strains with different donor potential. The excision event was suggested to be insufficient for conjugal transfer to occur and that there was no linear relationship between Enterococcus faecalis strains and either the excision frequency of pAT112 or the copy number of Tn916 circular intermediates per cell in the hosts.

The inlA gene encodes for the 80 kDa protein internalin in the gram-positive bacterium Listeria monocytogenes. Internalin allows the bacterium to multiply in host cells. The distribution and the DNA polymorphisms of inlA sequences in various wild strains of L. monocytogenes are compared to other Listeria species. Results indicate that L. monocytogenes is the only Listeria specie in which inlA required for cell invasion is expressed.

Clinical features and molecular characterization of 109 group B streptococci causing neonatal invasive infections were determined over an 18-month period in France. Sixty-four percent of the strains were from late-onset [...]